NCT05312164 is a clinical trial of HF-OCT Imaging in Coronary Stenosis, sponsored by Gentuity, LLC.

Who is sponsoring NCT05312164?

NCT05312164 is sponsored by Gentuity, LLC.

What drugs are being tested in NCT05312164?

Interventions in NCT05312164: HF-OCT Imaging, FFR Pressure Wire, Angiography.

What condition does NCT05312164 study?

NCT05312164 studies Coronary Stenosis.

Is NCT05312164 still recruiting?

NCT05312164 is currently recruiting now. Last updated 20 March 2025.

Last reviewed 2025-03-20 · How we verify

NCT05312164

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physio-Anatomy Clinical Data Collection Study

Recruiting now Last updated 20 March 2025

What this trial tests

trial testing HF-OCT Imaging in Coronary Stenosis in 150 participants. Currently enrolling.

Timeline

14 March 2022

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Gentuity, LLC
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	150
Start date	14 March 2022
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	6 locations across United States

Drugs / interventions tested

HF-OCT Imaging
FFR Pressure Wire
Angiography

Conditions studied

Coronary Stenosis — all drugs for Coronary Stenosis →

Sponsor

Gentuity, LLC

Who can join

18 and older, any sex, with Coronary Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Stenosis

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
NCT05709652 — Impact of Fast-rotation Coronary CT in Patients Undergoing Aortic Stenosis Workup · NA · recruiting
NCT06376630 — Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI · NA · recruiting
NCT04014140 — iFR Guided Coronary Artery Bypass Grafting Surgery · recruiting

Other Gentuity, LLC trials

Trials by the same sponsor.

NCT06685783 — Vis-Rx Prime Micro-Imaging Catheter Study · completed
NCT04533503 — Vis-Rx Post-Market Evaluation · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05312164 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gentuity, LLC
Last refreshed: 20 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05312164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing